Главная › Метастатический рак › Орегон › Portland
Клинические исследования Метастатический рак в городе Portland, OR
29 исследований по теме Метастатический рак ищут участников в центрах в городе Portland и поблизости (в радиусе около 30 миль). Откройте исследование, чтобы узнать критерии участия и контакты исследовательской группы.
Официальный текст исследования (на английском)
Ищете участников для исследования? Разместите его вверху страницы — $99 на 30 дней →
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Набор участниковФаза 3
- Oregon Health and Science University, Portland
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Набор участниковФаза 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Oregon Health and Science University, Portland
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Набор участниковФаза 1/2
- Oregon Health & Science University (OHSU), Portland
A Study of ASP3082 in Adults With Advanced Solid Tumors
Набор участниковФаза 1
- Oregon Health and Science University, Portland
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Набор участниковФаза 1
- ALX Center 6, Portland
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Набор участниковФаза 2/3
- Oregon Health and Science University, Portland
First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
Набор участниковФаза 1/2
- Oregon Health & Science University, Portland
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Набор участниковФаза 3
- Kaiser Permanente Interstate Medical Office Central, Portland
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Набор участниковФаза 2
- Oregon Health and Science University, Portland
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Набор участниковФаза 2/3
- OHSU Center for Health & Healing 1, Portland
- Oregon Health and Science University, Portland
- OSHU Center for Health and Healing 2, Portland
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Набор участниковФаза 3
- Northwest Cancer Specialists, P.C., Portland
A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread
Набор участниковФаза 1
- Providence Portland Medical Center, Portland
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Набор участниковФаза 3
- Providence Portland Medical Center, Portland
- Kaiser Permanente Interstate Medical Office Central, Portland
- Oregon Health and Science University, Portland
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Набор участниковФаза 3
- Providence Portland Medical Center, Portland
- Providence St. Vincent Medical Center, Portland
- Kaiser Permanente Interstate Medical Office Central, Portland
- и еще 1
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Набор участниковФаза 3
- Oregon Health and Science University, Portland
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Набор участниковФаза 1/2
- Northwest Cancer Specialists, P.C., Portland
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Набор участниковФаза 3
- Providence Portland Medical Center, Portland
- Providence St. Vincent Medical Center, Portland
- Kaiser Permanente Interstate Medical Office Central, Portland
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
Набор участниковФаза 2
- Research Site, Portland
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Набор участниковФаза 1/2
- Oregon Health and Science University, Portland
A Study of MGC026 in Participants With Advanced Solid Tumors
Набор участниковФаза 1
- Providence Cancer Institute, Portland
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Набор участниковФаза 1/2
- Oregon Health & Science University, Portland
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Набор участниковФаза 3
- Research Site, Portland
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
Набор участниковФаза 1
- Investigative Site #121, Portland
Axatilimab in Combination With Retifanlimab and Paclitaxel for the Treatment of Patients With Advanced or Metastatic Solid Tumors
Набор участниковФаза 1/2
- OHSU Knight Cancer Institute, Portland
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
Набор участниковФаза 2
- VA Portland Health Care System, Portland
Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study
Набор участниковФаза 4
- OHSU Knight Cancer Institute, Portland
Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors
Набор участниковФаза 1
- Providence Cancer Institute, Portland
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
Набор участниковФаза 3
- Oregon Health & Science University Knight Cancer Institute, Portland
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Набор участниковНаблюдательное исследование
- Massive Bio SYNERGY-AI site, Portland
Исследования Метастатический рак в других городах
- Houston, TX104 исследований
- New York City, NY93 исследований
- Nashville, TN70 исследований
- Boston, MA63 исследований
- Los Angeles, CA57 исследований
- St. Louis, MO54 исследований
- Arlington, VA53 исследований
- Philadelphia, PA46 исследований
- Chicago, IL45 исследований
- San Antonio, TX44 исследований
- Washington, DC43 исследований
- Dallas, TX42 исследований
Другие исследования в городе Portland
- Немелкоклеточный рак легкого46 исследований
- Рак (все виды)34 исследований
- Рак молочной железы33 исследований
- Рак простаты33 исследований
- Колоректальный рак28 исследований
- Рак яичников27 исследований
- Рак легких26 исследований
- Острый миелоидный лейкоз25 исследований
- Рак эндометрия24 исследований
- Плоскоклеточный рак головы и шеи19 исследований
- Рак поджелудочной железы19 исследований
- Сердечная недостаточность17 исследований
Источник: ClinicalTrials.gov, данные получены 6 окт. 2026 г.. Каждая исследование устанавливает свои критерии участия; решение о включении принимает исследовательская группа.